Pediatric Allergy & Immunology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: A&I, peds allergy, allergy/immunology. Multidisciplinary subspecialty fellowship, entered from Pediatrics or Internal Medicine. One conjoint board (ABAI, sponsored by ABP + ABIM). Organ system: the immune system in children, across airways, skin, GI tract, and the immune system itself.

The 30-second version

Pediatric Allergy & Immunology is the rare peds-adjacent path where both the lifestyle and the pay are genuinely good, the door out of the pediatric pay ceiling without leaving the kids or the humane hours behind. It's almost entirely outpatient: you run a clinic, follow food-allergic, asthmatic, and eczema-prone kids (and often their whole families) for years, and go home with no ward rounds and no overnight pager. The clinical substance is far deeper than the "sneezes and EpiPens" caricature. Pediatric clinical immunology spans food-allergy immunotherapy, drug reactions, eosinophilic disease, mast-cell disorders, and the cerebral core of inborn errors of immunity. Two facts make it stand out for a pediatrics-bound student: it is the great exception to the pediatric "fellowship penalty," out-earning general pediatrics and most peds subspecialties, and the fellowship is unusually short at just 2 years. The whole catch is on the front end: the fellowship is small and competitive, so the field rewards planning early.

A note on framing. A&I is a shared, multidisciplinary field, not a pediatric subspecialty in the way pediatric cardiology is. You enter it from either a Pediatrics or an Internal Medicine residency, both routes feed the same 2-year ACGME fellowships, and everyone sits the same conjoint board. "Pediatric A&I" is a practice orientation rather than a separate board: an allergist, usually Peds-trained, whose panel is mostly or entirely children. This page frames the field around the pediatric entry route while keeping that shared nature front and center.¹

Quick dashboard (details and sources below)


Training after med school	Peds (or IM) residency (3) + A&I fellowship (2 — a short fellowship) = 5 years
Total from college start	~13 years (4 undergrad + 4 med school + 3 residency + 2 fellowship)
Competitiveness (as a fellowship)	Competitive — small field, ~99% fill, ~1.4 applicants/position ⟳
Typical full-time pay	$308,846 (Survey · Doximity 2025, adult A&I as proxy); ~$310k–$360k across sources, private practice higher ⟳
Pay range (structure)	25th pct ~$310k · median ~$360k · 75th pct ~$390k · 90th ~$450k (SalaryDr panel, n=39) ⟳
Lifestyle	Outpatient, ~40–44 hrs/wk, essentially no overnight call — among the best in medicine
Burnout	35% of allergists (Medscape Allergist Lifestyle, Happiness & Burnout Report 2023); no cross-specialty rank is published for the field ⟳
% women	~43% practicing; ~68% of fellows in training ⟳
DO / IMG accessibility	Opening up: 21.7% DO and 14.9% IMG of matched positions (2026 appointment year), both five-year highs ⟳

Two-step entry note: you do not match into A&I out of medical school. You first complete a full Pediatrics residency (an accessible and unusually IMG-friendly route), become board-certified by the ABP, and only then apply to the 2-year A&I fellowship through the NRMP Medicine & Pediatric Specialties Match, where you compete alongside IM-trained applicants for the same seats.

What they actually do

Pediatric allergist-immunologists diagnose and treat disorders of the immune system in children, which in practice means a lot more than hay fever.² The bread-and-butter is heavily pediatric: food allergy (the defining growth area, through oral food challenges and oral immunotherapy), atopic dermatitis/eczema, asthma, allergic rhinitis, chronic urticaria (hives), drug allergy, and insect-sting allergy. But the specialty's intellectual core is clinical immunology: inborn errors of immunity, the 400-plus distinct genetic disorders of primary immunodeficiency, many of which present in infancy with recurrent infections or failure to thrive, immune dysregulation, mast-cell disease, and eosinophilic disorders like eosinophilic esophagitis. The defining skill is the diagnostic reasoning to sort out why a child's immune system is over-reacting, under-reacting, or attacking the wrong target, and then to modify the disease rather than just suppress a symptom.²

The work is outpatient, continuity-based, and conversation-heavy. In pediatrics, most of that conversation is with anxious parents. You build relationships that run for years, often across siblings, and you spend real time counseling: anaphylaxis action plans, epinephrine-autoinjector teaching, allergen avoidance, asthma controller regimens. A careful allergy history is frequently the whole diagnosis. There's just enough hands-on work to keep it from feeling purely cognitive.²

Representative procedures: skin-prick and intradermal allergy testing · patch testing (contact dermatitis) · spirometry / pulmonary function testing · oral food challenges (graded, supervised feeding that can occupy a room for hours) · drug challenges and desensitization (e.g., penicillin de-labeling) · allergen immunotherapy ("allergy shots," SCIT) and sublingual immunotherapy (SLIT) · oral immunotherapy (OIT) for food allergy (Palforzia and center-based protocols) · administration of biologics (anti-IgE, anti-IL-4/13, anti-IL-5). These procedures are office-based, low-morbidity, and revenue-generating, which matters for the economics below.²

A day in the life: A typical clinic day runs roughly 8:30 to 5–6, four to five clinical days a week, often with a half- or full day protected for administration and no hospital rounds. You see somewhere around 15–22 patients, a mix of new consults (the detective work) and follow-ups (asthma control, immunotherapy progress, food-challenge results). A skin-testing session, an oral food challenge, or a drug desensitization punctuates the schedule. Overnight call is minimal to none, even in academic centers, and weekends are largely free. That is the opposite of the high-acuity, heavy-call pediatric corners like neonatology and the PICU.³

The training path & time to completion

This is a shared, multidisciplinary fellowship with a two-step entry, reachable from two different residencies. This page frames the pediatric route.

Medical school (4 yrs) → Pediatrics residency (3 yrs) [or Internal Medicine, 3 yrs] → A&I fellowship (2 yrs) → board-eligible with ABAI.¹

Two-step entry note: you do not match into A&I out of medical school. You first complete a full residency, Pediatrics for the purposes of this page, and become board-certified by the ABP, then apply to A&I fellowship through a separate, later match. The upside of that structure: your residency itself is a complete, stable career, so your fallback if A&I doesn't work out is already a good one (see the FLI angle).

A short, 2-year fellowship, and a real distinguishing feature. ACGME A&I fellowship is a minimum of 24 consecutive months; most programs are 2 years (research-track programs may run 3). At 2 years it is one of the shortest subspecialty fellowships in medicine, where most are 3, which keeps the total training path shorter than nearly every other medical or surgical subspecialty. Combined with the outpatient, low-call practice, that short tail is a frequently cited draw.¹⁴ ⟳
Shared entry (Peds or IM): both routes feed the same ACGME-accredited fellowships and the same board exam, and all fellows are trained to care for both adults and children regardless of which residency they came from. Peds and IM applicants compete against each other in a single combined match.¹
The fellowship match: A&I fills through the NRMP Medicine and Pediatric Specialties Match (the "December match" run by the Specialties Matching Service), which is separate from the medical-school Main Match.⁵
The board is a conjoint one: the American Board of Allergy and Immunology (ABAI) is jointly sponsored by the American Board of Internal Medicine (ABIM) and the American Board of Pediatrics (ABP). You must first be certified by ABP (or ABIM) before you can sit the ABAI exam, which is exactly why either residency route qualifies you for the identical A&I credential. Pediatric A&I is a practice orientation on the single ABAI credential rather than a separate board certificate.¹
Total from the start of college: ~13 years (4 undergrad + 4 med school + 3 residency + 2 fellowship).

How competitive is it? (as a fellowship)

A&I is a small and genuinely competitive fellowship, and the competition looks different from a med-school-Match specialty because the applicant pool is already filtered (everyone applying has finished a residency) and the number of seats nationally is tiny. The binding constraint is seat count, not a brutal ratio.

The most recent cycle, the 2026 appointment year (Match Day 3 December 2025), shows the shape of the field clearly in NRMP's Results and Data 2026:⁵ ⟳

177 positions across 101 programs and 175 filled, a 98.9% fill rate, with only 2 programs left with an open spot.
241 applicants ranked A&I for those 177 positions, an applicant-to-position ratio of ~1.4:1.
Small footprint overall: FREIDA counts 92 ACGME-accredited programs and ~345 active fellows on duty nationally.⁴ ⟳ (NRMP's 101 vs. FREIDA's 92 reflects NRMP counting participating program tracks; both are cited.)

The honest read: nearly every seat fills (~99%) and a meaningful share of applicants go unmatched, so it is genuinely competitive, though not at the near-impossible, dermatology-fellowship level. The constraint is the small number of seats, not a punishing ratio; because the field is a well-known lifestyle-and-pay destination, strong applicants self-select in, which is what keeps fill rates near 99%. The practical takeaway: this is a spot you build toward from early on rather than drift into late from a Pediatrics residency (see the FLI angle). The good news is that the front door, Pediatrics residency, is itself one of the more accessible routes in medicine, and an unusually IMG-friendly one, taking 30.4% of its filled positions from international graduates in 2026 against 25.2% across all PGY-1 positions; its DO share is at the all-specialty average rather than above it. So the pipeline is reachable even though the fellowship is competitive.⁶

DO / IMG accessibility is moderate and moving. Of the 175 matched A&I positions in the 2026 appointment year: US MD 62.9%, DO 21.7%, total IMG 14.9% (US-citizen 5.7% + non-US 9.1%), Canadian 0.6%. That is more open than the most gatekept fellowships and less open than the most IMG-heavy ones, but the direction of travel is worth naming: the DO share is a five-year high and the US MD share a five-year low, having run 68.7% · 68.6% · 66.9% · 71.9% · 62.1% of positions offered across the 2022 to 2026 cycles.⁵ ⟳

Compensation — the robust version

A "limited data" flag up front, and it matters. No branded survey breaks out "pediatric allergist" as a separate line. Doximity publishes no pediatric allergy and immunology row at all, and Doximity, Medscape, MGMA, and SalaryDr — whose allergy panel is 39 physicians — all report "Allergy & Immunology" as one specialty without splitting peds-entry from IM-entry earnings. Every A&I figure on this page, including the Doximity one, is the combined adult-and-pediatric number standing in as a proxy. So the peds-vs-IM earnings difference isn't publicly broken out (limited data), and any difference is driven by practice setting and payer mix (peds-trained allergists skew somewhat more academic/pediatric, which directionally pulls toward the lower end), not by which residency you came from. Every number below is for A&I as a whole.⁷

A&I pay is also unusually spread out and unusually misread by headline surveys, for one structural reason: much of A&I's economics runs on outpatient ancillary revenue that RVU-based employment models barely credit: allergy shots, in-office testing, and buy-and-bill biologics. Physicians who own that revenue (private practice, partners) earn dramatically more than the RVU-only employed median. Treat Medscape as the anchor for employed/broad-survey magnitude and SalaryDr / Physician Side Gigs as the window into private-practice reality, while noting those latter samples are small and self-reported.⁸⁹¹⁰

National number. Doximity's 2025 report (2024 earnings, about 37,000 US physicians) puts Allergy & Immunology at $308,846.⁷ ⟳ Around it, the field lands anywhere from ~$255,000 (FastRVU's employed/RVU planning median, the aggregator's own model rather than a licensed MGMA table) to ~$360,000 (SalaryDr median, private-practice-skewed), and Medscape's broad survey runs ~$319,000 (2025 report) falling to ~$310,000 (2026 report, −3% YoY), ranking A&I roughly 22nd of 29 specialties.⁸ A defensible "typical full-time" figure for 2025–26 is ~$310,000–$360,000 total compensation, with private-practice owners running well above that.⁸¹⁰ ⟳

A&I is the great exception to the pediatric "fellowship penalty," and it is worth being exact about the size of the exception. Almost every other pediatric subspecialty pays less than general pediatrics after three extra fellowship years, which is the field's notorious paradox. A&I breaks it: at $308,846 it clears general Pediatrics ($265,230) by about $44,000 and out-earns most pediatric subspecialties. But it is fourth among the fields a pediatrician can enter, behind neonatology, pediatric cardiology, and pediatric emergency medicine, rather than second.⁷ ⟳

Field a pediatrician can enter	Avg comp (Doximity 2025, 2024 earnings)
Neonatology / Perinatology	$354,841
Pediatric Cardiology	$352,197
Pediatric Emergency Medicine	$312,271
Allergy & Immunology	$308,846
Pediatric GI	$298,457
Pediatric Pulmonology	$282,000
General Pediatrics	$265,230
Pediatric Nephrology	$263,013
Pediatric Heme/Onc	$255,733
Pediatric Infectious Disease	$248,322
Pediatric Rheumatology	$231,574
Pediatric Endocrinology	$230,426

(Three fields sit above A&I, and each buys the difference with acuity or hours: neonatology is NICU nights, pediatric cardiology is procedural, pediatric emergency medicine is shift work. Among the outpatient, low-call paths a pediatrician can take, A&I is still the clear compensation winner.) The reason is procedural/ancillary revenue: allergy shots, in-office testing, and buy-and-bill biologics are exactly what lets a "kids' doctor" clear the general-peds ceiling.⁷¹¹

The spread (structure, from SalaryDr 2026, a small and private-practice-skewed sample): 10th pct $290k · 25th $310k · median $360k · 75th $390k · 90th $450k.⁹ ⟳ Realized high-end outliers reach $500k+ for owner/partners with heavy immunotherapy and biologics volume; the low end (early-career, low-volume, RVU-employed) can sit near $210k on MGMA benchmarks.⁹¹⁰ ⟳

Seniority helps, but ownership is the real lever. SalaryDr's progression runs entry-level (0–2 yrs) ~$340k → mid-career ~$353k → experienced (11–15 yrs) ~$440k.⁹ But the biggest jump isn't tenure. It's buying into a practice, which converts you from a wage-earner into an owner of the immunotherapy/testing/biologics revenue stream. Practice owners derive ~44.7% of comp from productivity vs. 22.3% for employees.¹¹ ⟳

Academic vs. private practice: A&I's defining split, and where the peds-entry caveat bites. Because owners capture ancillary revenue, private practice pays far more than academia here:

Group private practice (independent + PE-backed): avg ~$342,000, up to ~$500,000.¹⁰
Academic hospitals / children's hospitals: ~$236,000. The lowest setting, skewed toward research/protected time.¹⁰
The academic-to-private gap in A&I can be $100k–$250k+, one of the widest setting-based spreads of any outpatient specialty.¹⁰ ⟳
Peds-entry relevance: peds-trained allergists are somewhat more likely to land in academic children's-hospital settings (the ~$236k tier), which would pull peds-entry comp toward the lower end vs. IM-entry docs who more often go straight into adult private practice. This directional inference is not survey-confirmed (limited data). The lucrative private-practice path is fully open to peds-trained allergists too, and many of the highest earners see both kids and adults.⁷

Geography: no A&I-specific figure exists. This page used to print a metro ladder and a set of state medians from SalaryDr. They are not about this specialty; see ⁹. ⟳

Urban vs. rural. Directionally, rural/underserved areas can offer a scarcity premium (few allergists), but A&I revenue depends on patient density to sustain immunotherapy and biologics volume, so many rural markets can't support a full A&I practice, which blunts the usual rural-pays-more pattern. No survey publishes a clean A&I-specific urban-vs-rural dollar gap (limited data).¹⁰ ⟳

Starting-package extras (Physician Side Gigs, 2023–25): sign-on bonus (28% received, avg $18k), relocation (26% received, avg $12k), CME stipend (67% received, avg $2.6k), ~22 vacation days; average student-loan debt at graduation ~$193k.¹⁰ ⟳

The trend that colors all of it: the biologics and food-allergy boom. The biggest upward driver of A&I income in the 2020s is the rapid expansion of biologic indications (severe asthma, atopic dermatitis, chronic urticaria, eosinophilic esophagitis, and now food allergy) plus the food-allergy OIT/Palforzia revolution. Practices that buy and administer these high-cost drugs capture the margin, a windfall that flows to owners rather than to RVU-employed physicians. At the same time, the industry drift toward RVU-productivity pay actively "devalues compensation from allergen immunotherapy," squeezing employed allergists and pushing income-maximizers toward ownership. Private-equity roll-ups of A&I groups are now consolidating that ancillary revenue at scale.¹¹¹² ⟳

Lifestyle & the outpatient bargain

The single most-cited pro of A&I: it is, by most measures, the closest thing medicine has to a controllable-lifestyle-and-high-happiness combination, and within pediatrics it is the calm mirror image of neonatology and the PICU. It's outpatient and clinic-based (office hours typically ~8:30-to-6), essentially no overnight call even in academic centers, predictable hours (self-reports cluster around ~40–44 hrs/week), and weekends largely free.³ Schedule control is excellent, especially in private practice, where you set your own clinic template. Part-time or tapered arrangements are unusually feasible, a major reason parents and caregivers of any kind gravitate here.³

The trade-off is the mirror image of that comfort, and it is about content rather than hours. This is not a procedure-heavy or OR-based life; the "procedures" are testing, challenges, and injections. Bread-and-butter clinic (recurrent rhinitis, hives, routine asthma follow-ups) can feel repetitive to someone who craves acuity or the variety of a crisis. And the field's one hard structural catch sits before you ever start practicing: the small, competitive fellowship. But once you're in, the lifestyle is the whole point, and it largely delivers.

Lifestyle rating: 5/5. High on both predictability and control: defined outpatient hours, minimal call, and real say over your own schedule, especially as an owner.

Wellbeing — the part that's genuinely a strength

Unusually for these profiles, the wellbeing section here is mostly good news, and the one measure that isn't deserves its space.

Burnout: 35% of allergists, in the one report that measures the field directly. That is Medscape's Allergist Lifestyle, Happiness & Burnout Report 2023, relayed by Healthgrades, alongside 8% reporting depression and 14% reporting both. The published cross-specialty tables carry no allergy row to set beside it, so this page gives no cross-specialty rank.¹³ ⟳ The structural reasons to expect a favorable number are the outpatient, low-acuity, no-call shape of the work. (The general pattern in cross-specialty data: emergency medicine, OB/GYN, and primary care highest; the low-acuity outpatient/lifestyle fields lowest.) One split inside that same report is worth carrying, because this page also reports that about 68% of A&I fellows in training are women: 76% of female allergists reported burnout, depression, or both, against 49% of their male colleagues.¹³ ⟳

Happiness & satisfaction, on two different questions that give two different answers. Asked whether doctors in their specialty can be happy and well-balanced, allergists/immunologists top all 29 fields at about 94% (Medscape 2025, via Healthgrades).¹³ ⟳ Asked whether they personally are happy outside of work, the same instrument's 2023 allergist report puts them at 55%, down from 79% before the pandemic, and fifth-lowest of 29 on that measure.¹³ ⟳ Both numbers come from the same footnote and they are not in conflict, because they ask different things: one is about what the job structurally permits, the other about how a cohort felt in one pandemic-shadowed year. The gap between them is more interesting than either half, and it is the reason to treat the field's lifestyle reputation as a claim about the structure of the work rather than a promise about how you will feel. SalaryDr's own panel, 39 verified submissions, rates the specialty 4.0 out of 5 and reports 90% saying they would choose it again.¹⁴ ⟳ A candid caveat on volatility: A&I had a sharp reported dip in work-life balance in the 2022 Medscape cycle, so year-to-year survey swings on this instrument are real.¹⁴ ⟳

Meaning, in its pediatric flavor. For a peds-focused allergist, meaning comes from disease-modifying care and long continuity: you watch a peanut-allergic toddler you first challenged grow into a teenager who can eat safely, you retrain immune systems with immunotherapy rather than just suppressing symptoms, and occasionally you catch a life-threatening inborn error of immunity that everyone else missed. And you build relationships with whole families over years, often across siblings.¹⁵¹⁶

Career longevity is a real feature. The low physical toll and strong schedule control mean allergists tend to practice long, often shifting to part-time rather than fully retiring. Where many specialties treat their subspecialties as burnout off-ramps, A&I is closer to being the off-ramp other physicians envy.

Who's in the field (demographics)

Women: ~43% of active practicing allergists (up from ~30% in 2010), and a clear majority of the pipeline: ~68% of A&I fellows in training, ~54% of faculty, and ~55% of program directors are women. One of the more female-represented physician subspecialties, and rapidly shifting. The pediatric-entry cohort likely skews even more female given Pediatrics residency's high female share, though this isn't separately published (limited data).¹⁷ ⟳
DO: 21.7% of matched fellowship positions (38 of 175, 2026 appointment year), up from 15.2% the year before and the highest DO share in five cycles.⁵ ⟳
IMG: 14.9% of matched positions (26 of 175, US-citizen 5.7% + non-US-citizen 9.1%); US MD graduates take 62.9%, and one Canadian graduate makes up the balance.⁵ ⟳
Peds-entry vs. IM-entry split: not published in NRMP, ABAI, AAAAI, or ACGME public sources at this granularity (limited data). The general understanding is that IM-entry outnumbers Peds-entry, given the larger IM pipeline, but no current split is published.⁷
URiM: NRMP, ACGME, and AAAAI do not publish an A&I-specific underrepresented-in-medicine breakdown at this granularity. (limited data)⁵

Culture, personality & the online stereotypes

The real pattern, said plainly and attributed to the field's reputation and the online read, not stated as fact and not a verdict on any individual. Plenty of pediatric allergists don't fit the mold.

Who gravitates here: cerebral immunology lovers who want a genuinely controllable, family-compatible life without leaving medicine's intellectual deep end. The archetype is someone who found immunology fascinating in med school (one of the densest subjects in the curriculum), liked clinic more than the wards, enjoys long and probing conversations, is good with kids and their anxious parents, and consciously prioritized life outside work, while still wanting enough of a hands-on element (skin testing, food and drug challenges, immunotherapy) to not feel purely cognitive. As one allergist put it to the AMA: if immunotherapy strikes you as genuinely cool, you'll probably love the field.¹⁵

The reputation (community perception, paraphrased): happy, balanced, intellectually curious, low-drama, and, in a word that comes up a lot, content. Pediatric allergists in particular are read as warm, patient, kid-friendly, and family-oriented; people who value steady outpatient continuity and predictable evenings over prestige or adrenaline. The field is widely envied for its "great lifestyle + good pay + genuinely interesting immunology" combination, and it's understood to be competitive to enter precisely because it is so livable. The good life is the reason everyone wants in. That's the honest read of the reputation; plenty of people in the field don't match it, and the immunology itself is anything but low-effort.

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

"It's just sneezes and EpiPens." The most persistent one, and the one people in the field push back on hardest. Reality: pediatric clinical immunology (inborn errors of immunity, mast-cell disease, drug reactions, eosinophilic disorders) is one of the most intellectually demanding, fastest-advancing corners of medicine.
"The lifestyle specialty for people who don't want to work hard." Reality: the fellowship is competitive precisely because the lifestyle is real and known. You work hard to get in, and the immunology is genuinely difficult.
"Chill and well-paid, but impossible to get into." Reality: it's competitive, but the constraint is the small number of seats rather than a dermatology-level ratio. Plannable, not hopeless.
"Not real doctors / no acuity." Reframes the field's actual value, which is disease-modifying outpatient care and complex immunology, as if hospital acuity were the only real medicine.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, allergists come across as some of the happiest, least-burned-out physicians on the forums. Lifestyle-minded residents float A&I constantly, and then discover that the constraint is landing a spot rather than the work, because programs are few and applicant pools strong. There's a recurring debate over whether the pay "should" be higher given the training length, usually answered with near-universal agreement that the quality of life more than makes up for it. And there's a steady undercurrent of correcting the "it's just allergies" stereotype by pointing to immunology depth and the biologics/food-allergy revolution. The through-line: people who match into A&I rarely regret it.

Voices from the field. Paraphrased from public writing, with links to the originals:

Dr. Burcin Fraser, in the AMA's "Shadowing" series, describes most of her patients as healthy, the work centered on prevention and disease-modifying care for food allergy, rhinitis, and asthma. She notes that moving to private practice sharply reduced the burnout she'd felt in hospital settings.¹⁵
Dr. Alnoor Malick, also via the AMA, says he chose A&I for its all-ages patient mix and its blend of acute and chronic disease, and describes his life as exactly what he wanted: clinical medicine with minimal after-hours call and protected family time.¹⁸
The AAAAI's "A Rewarding Career in Allergy/Immunology" frames the draw as lifelong patient relationships across all ages plus a rapidly advancing science base spanning food allergy, drug allergy, immunodeficiency, and eosinophilic/mast-cell disease.¹⁶

Why people choose it / why people leave

Why choose it: best-in-medicine work-life balance (outpatient, no overnight call, predictable clinic hours, real schedule control) · the highest share in medicine agreeing the field allows a happy, balanced life, and 90% on SalaryDr's 39-physician panel saying they would choose it again · the great exception to the pediatric pay penalty, with solid pay that clears the general-peds ceiling, strong per-hour economics, and private-practice upside · a short 2-year fellowship · intellectually rich, since pediatric clinical immunology is deep and moving fast (biologics, oral immunotherapy, inborn errors of immunity) · long-term continuity with kids and families, often across siblings · excellent career longevity (taper rather than retire) · reachable from an accessible Pediatrics residency, with a real fallback career.

Why leave or avoid it: if you want a procedure-heavy or OR-based career, this isn't it, because the "procedures" are testing, challenges, and injections · compensation trails surgical and high-procedure fields, and a purely pediatric/academic panel pays less than adult-mixed private practice, so it's the wrong pick if maximizing income is the top priority · bread-and-butter clinic can feel repetitive to someone who craves acuity · the fellowship is small and competitive, so access is a front-loaded cost you can't coast through · employed/RVU roles are structurally underpaid relative to owners · two more years of deferred income before the attending jump.

Best fit if: you genuinely enjoyed immunology and like long, probing conversations · you're good with children and their worried parents · you want a controllable, family-compatible life without leaving medicine's intellectual deep end · you're comfortable in a mostly-outpatient, continuity-based practice · you're patient and a good listener, because the field rewards taking the extra five minutes.

Not for you if: you need the OR, high procedural volume, or acuity/adrenaline to stay engaged · you're optimizing purely for maximum salary · you dislike outpatient clinic and long-term patient management · you don't actually find the immunology interesting (the "it's just allergies" version gets old fast if the science doesn't grab you) · you need to start earning at full attending pay the moment residency ends.

The FLI angle — Pediatric A&I for first-gen, low-income & immigrant students

Pediatric A&I deserves a real spotlight for FLI students, because it is the rare peds-adjacent path where both lifestyle and pay are genuinely strong, a combination most of pediatrics simply doesn't offer. General pediatrics is beloved but among the lowest-paid physician fields; A&I is the door out of that pay ceiling without leaving the pediatric patients or the humane hours behind. If your priorities are stability, controllable hours (which matter enormously if you're supporting family or carrying caregiving responsibilities), and a solid income without the punishing grind, this field is built for exactly that. The kind realism: the destination is excellent and the on-ramp is unusually forgiving, but the door is narrow and it closes if you wait.

Where it fits FLI realities well:

The on-ramp is accessible, and the fallback is a real career. You don't need a hyper-competitive residency first. A&I opens off a standard Pediatrics residency, one of the more open routes in medicine and an unusually IMG-friendly one, though its DO share only matches the all-specialty average.¹⁶ That matters enormously without a financial safety net: if A&I fellowship doesn't work out, staying a general pediatrician is already a complete, stable, well-paying career. Low downside risk is a genuine, underrated advantage of this path.
The payoff matches FLI priorities better than almost any peds path. Predictable lifestyle + long career longevity + income that clears the general-peds ceiling = exactly the stability and quality-of-life profile that's valuable when you're the first in your family in medicine and may be helping support others. And the earning comes without a permanent nights-and-weekends toll, a real contrast to hourly/shift fields. It's one of the smartest lifestyle-to-effort trades a pediatrics-bound student can aim for.
Ownership is a real wealth lever. The private-practice immunotherapy/testing/biologics revenue stream is where the money is; owners earn far more than employed/RVU physicians. For a first-gen physician, buying into a practice is a genuine wealth-building path, and the business side of medicine is worth learning early, since that's knowledge FLI trainees are less likely to arrive with.

Risks to name honestly:

It's competitive to match, and the bottleneck is front-loaded. Few programs, few spots, strong applicant pools: nearly every seat fills and a meaningful share of applicants go unmatched. The real constraint is the small seat count, not a brutal ratio, but you cannot drift into this late. You need a strong overall residency record. Translate that into concrete moves during Pediatrics residency: get involved in A&I research or QI, find A&I mentors and letter-writers early, do an away/elective rotation, and network with programs well before application season. The competition rewards planning, not luck.
Pediatric-heavy tends to pay less than adult-mixed. The best A&I economics come from volume and ancillary revenue, and adult panels tend to sustain more of it; many of the highest-earning "pediatric" allergists in fact see both kids and adults. A purely pediatric, academic panel will pay less than a mixed private practice. That's a real trade-off to go in with eyes open (and remember: the peds-vs-IM earnings split isn't publicly broken out, so this is a directional pattern rather than a published figure).
Academic immunodeficiency work is geographically concentrated. If your draw is the cerebral end of inborn errors of immunity and complex immune dysregulation, that work clusters at major academic children's centers in specific metros. It can constrain where you live, which matters if family or community ties keep you rooted in one place. (General allergy practice, by contrast, is far more geographically flexible.)
The extra 2 years is real deferred income. Fellowship means two more years at trainee wages before the attending jump. It's a shorter deferral than most subspecialties (2 years, not 3), but it's real, so weigh it if you need to start earning fast. The flip side: general-peds attending income is available immediately if you don't pursue the fellowship.

Bottom line: an accessible on-ramp off a reachable residency, a safe fallback if it doesn't work out, humane and controllable hours, a short fellowship, and pay that clears the pediatric ceiling, with the single firm condition that you treat fellowship applications as a deliberate, early project rather than an afterthought. Honest and encouraging: for a pediatrics-bound first-gen student who wants stability and income and a life, this is one of the smartest trades in medicine, if you plan the runway.

Subspecialties & focus areas within A&I

Formal fellowships-within-the-fellowship are rare, but practice focus and academic niche vary a lot, and these are the clinical worlds a peds-oriented allergist can lean into:¹⁶²

Food allergy. The defining pediatric growth area: oral food challenges, oral immunotherapy (OIT/Palforzia), and now biologics. High patient/family engagement, strong outpatient continuity.
Inborn errors of immunity / clinical immunology. Primary immunodeficiency and immune dysregulation, much of which presents in childhood. The most immunology-heavy, cerebral corner; often academic and geographically concentrated at dedicated centers.
Asthma. Severe/difficult-to-control pediatric asthma and biologics management.
Eosinophilic & mast-cell disease. Eosinophilic esophagitis, hypereosinophilic syndromes, mastocytosis; a growing, biologic-driven niche overlapping GI and heme.
Drug allergy. Penicillin/antibiotic de-labeling, drug challenges and desensitizations; increasingly valued for antibiotic stewardship.
Atopic dermatitis / venom / urticaria & angioedema (including hereditary angioedema). Heavily pediatric allergic-disease bread and butter.

Fun facts

You can reach one of medicine's best lifestyles through either a Pediatrics or an Internal Medicine residency. A&I is one of the few subspecialties that accepts both paths into the same fellowship and the same board.¹
ABAI is the only conjoint board jointly sponsored by both the American Board of Pediatrics and the American Board of Internal Medicine, which is the structural reason the dual entry works and why "pediatric A&I" is a practice orientation rather than a separate certificate.¹
A&I is the great exception to the pediatric "fellowship penalty." Almost every other peds subspecialty pays less than general pediatrics after extra training; A&I clears general peds by about $44,000 and out-earns most peds subspecialties, because office procedures generate real ancillary revenue.⁷
The A&I fellowship is only 2 years, one of the shortest subspecialty fellowships in medicine, when most are 3.¹
Allergen immunotherapy ("allergy shots") is essentially disease-modifying, one of the few treatments in medicine that retrains the immune system rather than just suppressing symptoms.
Oral immunotherapy for food allergy, plus biologics like omalizumab now approved for it, has flipped a formerly "avoid it and carry an EpiPen" pediatric field into an actively therapeutic one within a single career span.
Women are the clear majority of the A&I pipeline: roughly 68% of A&I fellows in training are women, one of the more female-represented, fast-shifting, and family-friendly physician subspecialties.¹⁷
A&I is one of the calmest corners of pediatrics by design, the mirror image of neonatology and pediatric critical care, which are the high-acuity, heavy-call ends of the same specialty tree.

Sources

A&I shared/dual entry (Peds or IM), 2-year fellowship structure, combined match, all-ages training, and the ABAI conjoint board (jointly sponsored by ABP + ABIM; parent-board certification required first; single identical credential regardless of entry route). ABAI Conjoint Board (https://www.abai.org/conjboard.asp); ABAI/National Jewish Health certification-requirements PDF (2024) (https://www.nationaljewish.org/NJH/media/pdf/About-the-American-Board-of-Allergy-and-Immunology.pdf); American Board of Pediatrics, Allergy and Immunology (https://www.abai.org/conjboard.asp); AMA FREIDA, Allergy & Immunology (2024) (https://freida.ama-assn.org/specialty/allergy-and-immunology). ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹
What they do, procedures, and subfields (allergic disease, food allergy, immunotherapy/OIT, inborn errors of immunity/primary immunodeficiency, eosinophilic and mast-cell disease). Allergen immunotherapy, Oral immunotherapy, Primary immunodeficiency, and Allergy & immunology overviews (2026): https://en.wikipedia.org/wiki/Allergen_immunotherapy ; https://en.wikipedia.org/wiki/Oral_immunotherapy ; https://en.wikipedia.org/wiki/Primary_immunodeficiency ; https://en.wikipedia.org/wiki/Allergy_and_immunology ↩ ↩² ↩³ ↩⁴ ↩⁵
A&I outpatient schedule, ~40–44 hr/week, patient volume, and minimal-to-no overnight call. AMA "Shadowing" profiles (Fraser: ~4 clinical days, ~15–22 patients/day; Malick: 8:30–6, deliberate no-work-at-home) (https://www.ama-assn.org/medical-students/preparing-residency/what-its-allergy-and-immunology-shadowing-dr-fraser; https://www.ama-assn.org/medical-students/preparing-residency/what-it-s-allergy-immunology-shadowing-dr-malick); Med School Insiders, "So You Want to Be an Allergist/Immunologist" (https://medschoolinsiders.com/pre-med/so-you-want-to-be-an-allergist-immunologist/). (2024–2026.) ↩ ↩² ↩³
Fellowship length (min 24 consecutive months; most 2 yr, research-track up to 3) and program/fellow footprint (92 ACGME programs, ~345 active fellows). AMA FREIDA (2024) (https://freida.ama-assn.org/specialty/allergy-and-immunology); ABAI via National Jewish Health PDF (2024) (https://www.nationaljewish.org/NJH/media/pdf/About-the-American-Board-of-Allergy-and-Immunology.pdf). ↩ ↩²
Match/competitiveness and DO/IMG composition. NRMP Results and Data 2026 — Specialties Matching Service (2026 appointment year, Match Day 3 December 2025): 177 positions across 101 programs, 175 filled (98.9%), 241 applicants ranked A&I (~1.36:1), 2 programs with at least one unfilled position; Table 2 composition US MD 110 (62.9%), US DO 38 (21.7%), US IMG 10 (5.7%), non-US IMG 16 (9.1%), Canadian 1 (0.6%), the five summing to 175. Its Table 6A-series trend for the US MD share of positions offered runs 68.7% (2022), 68.6% (2023), 66.9% (2024), 71.9% (2025), 62.1% (2026); the DO share on the same denominator runs 17.7%, 15.4%, 17.2%, 15.0%, 21.5%. https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf (2026). Prior year for reference, NRMP Results and Data 2025 (2025 appointment year): 167 positions across 102 programs, 165 filled (98.8%), 246 applicants ranked; US MD 120 (72.7%), DO 25 (15.2%), Canadian 0, US IMG 4 (2.4%), non-US IMG 16 (9.7%) (https://www.nrmp.org/wp-content/uploads/2025/02/SMS_Results_and_Data_2025.pdf). No A&I-specific URiM breakdown published at this granularity (limited data). Corrected 2026-08-17: the dashboard, the competitiveness section and the demographics section all carried the 2025 composition as current, and reached the 2026 cycle only through a December 2025 news release for the headline fill rate. SMS 2026 published in February 2026 and moves every applicant-type figure, all of them toward more accessibility. The page also mixed denominators, pairing a US MD share computed on positions offered with DO and IMG shares computed on positions filled; every share above now uses positions filled, which is the denominator Table 2 prints. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
General Pediatrics as an accessible base-residency route. NRMP, Results and Data: 2026 Main Residency Match, Table 2: pediatrics (categorical) offered 3,126 positions and filled 2,951. Of those filled, 623 went to US DO seniors and graduates (21.1%) and 897 to IMGs, US-citizen and non-US combined (30.4%). The all-PGY-1 baselines in the same table are 21.5% DO and 25.2% IMG of 38,354 filled positions, so pediatrics is at the DO average and well above it on IMG. https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf Swept 2026-08-17: DO 21.1% and IMG 30.4%, both over the 2,951 positions filled, from Table 2 of that report. This footnote read "Peds ~18% DO of PGY-1 positions; ~99% DO senior match success; ~840 IMGs matched" and cited the NRMP match-data landing page rather than a report, so none of the three could be checked: the ~840 pins the edition to the 2025 Match (841 IMGs), ~18% matches no cycle from 2022 to 2026 on either denominator, and the ~99% was an all-specialty DO senior placement rate rather than a pediatrics figure. The three sentences citing it called the pediatrics door "DO/IMG-friendly"; on these numbers only the IMG half holds. A&I's own fellowship shares, which run above the residency on DO and below it on IMG, are separate and are in ⁵. ↩ ↩²
The pediatric "fellowship penalty" exception and peds-subspecialty pay comparison; and the "no separate pediatric-allergist benchmark" data gap. Doximity, 2025 Physician Compensation Report (published 2025; reports 2024 earnings from ~37,000 US physicians): Allergy & Immunology $308,846; neonatology/perinatology $354,841; pediatric cardiology $352,197; pediatric emergency medicine $312,271; pediatric gastroenterology $298,457; pediatric pulmonology $282,000; general pediatrics $265,230; pediatric nephrology $263,013; pediatric heme/onc $255,733; pediatric infectious disease $248,322; pediatric rheumatology $231,574; pediatric endocrinology $230,426. https://www.doximity.com/reports/physician-compensation-report/2025 (2025). Prior edition for reference: Doximity 2024 Physician Compensation Report, A&I $322,955 against general pediatrics $259,579. https://www.doximity.com/reports/physician-compensation-report/2024 (2024). Two limitations on the A&I figure. Doximity reports A&I as a single specialty with no peds-versus-IM split, so the peds-entry earnings difference is not publicly broken out (limited data). And Doximity publishes no pediatric allergy and immunology line at all, so $308,846 is the adult figure used as a proxy. Correction, 2026-08-13: this page previously called A&I "the single most important number on this page" and claimed it "out-earns general Pediatrics and every pediatric subspecialty except pediatric cardiology," repeated in the 30-second version, the figure caption and the fun facts. That was wrong on the 2024 table it cited, whose own printed rows put neonatology ($338,024) above A&I ($322,955), and it is wrong on the 2025 table, where A&I is fourth behind neonatology, pediatric cardiology and pediatric emergency medicine. The ladder above is rebuilt from the 2025 report, the rank is corrected to fourth, and the proxy caveat is now stated in the body rather than only here. The page's underlying argument survives: A&I still clears general pediatrics by about $44,000 and still out-earns most pediatric subspecialties, which is unusual in pediatrics. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
National figures and rank. Medscape Physician Compensation Report 2025 — A&I ~$319,000, rank ~22/29 (survey Oct 2024–Jan 2025), via Becker's (https://www.beckershospitalreview.com/compensation-issues/29-physician-specialties-ranked-by-pay-2/) and Kaplan (https://www.kaptest.com/study/mcat/doctor-salaries-by-specialty/). Medscape Physician Compensation Report 2026 — A&I ~$310,000, −3% YoY, rank ~22/29, via Weatherby (https://weatherbyhealthcare.com/blog/annual-physician-salary-report). FastRVU 2026 employed/RVU planning median ~$255,000; early-career ~$210,000 (https://fastrvu.com/specialties/allergy-immunology). (2025–2026.) Corrected 2026-08-17: these two figures were labeled "MGMA 2026 ... via FastRVU" here and "MGMA employed/RVU median" in the body. FastRVU's own site disclaims that lineage in as many words, stating it does not reproduce restricted benchmark datasets and is not produced by MGMA, AMGA, SullivanCotter, CMS or AMA, so the MGMA label has been removed and the host named in the visible sentence instead. The figures themselves are unchanged. ↩ ↩² ↩³
SalaryDr 2026 (n=39, self-reported, private-practice-skewed) — median $360k; percentiles P10 $290k / P25 $310k / P50 $360k / P75 $390k / P90 $450k; experience progression (~$340k entry → ~$353k mid → ~$440k experienced). https://www.salarydr.com/specialty/allergy-and-immunology (2026). Corrected 2026-08-17: SalaryDr's metro block is not specialty-specific, and the geography line built on it is gone. Fetched and compared line by line against SalaryDr's pain-management page, the "Popular Locations" list is identical on both: New York City $400,000 on 150 reports, Los Angeles $380,000 on 120, Boston $370,000 on 70, Miami $360,000 on 80, Chicago $350,000 on 100, Houston $340,000 on 90. The two specialties' own medians differ by $270,000 — $360,000 here on 39 verified submissions against $630,000 there on 26 — and the per-city report counts sum to 610, an order of magnitude above either panel. It is a site-wide ladder, so citing it as "A&I metro averages" attributed to this specialty a figure that is not about it. The state medians went with it for the same reason: SalaryDr's "View California pay" block reprints the national median unchanged, $360,000 here and $630,000 on the pain page. The panel median, the percentile ladder and the practice-type split are specialty-specific and stay. ↩ ↩² ↩³ ↩⁴ ↩⁵
Practice-setting split, starting-package extras, urban/rural, debt. Physician Side Gigs Average Allergist and Immunologist Salary (2023–25) — group private practice avg ~$342k (ceiling ~$500k); academic ~$236k; non-academic hospital $335k–$514k; sign-on 28%/$18k; relocation 26%/$12k; CME 67%/$2.6k; ~22 vacation days; ~$193k debt; declines to publish a field-wide average given the spread. https://www.physiciansidegigs.com/average-allergist-and-immunologist-salary . MedContractReview 2026 (no clean A&I urban-rural dollar gap) (https://medcontractreview.com/allergy-and-immunology-salary-earnings-growth-and-career-prospects/). (2023–2026.) ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸
A&I comp structure and the ownership lever. ACAAI "From the Desk of the EMD: How Are Allergists Paid?" — owners ~44.7% productivity vs. employees ~22.3%; immunotherapy/RVU economics; RVU weighting devalues immunotherapy. https://college.acaai.org/from-the-desk-of-the-emd-how-are-allergists-paid/ (accessed 2026). ↩ ↩² ↩³
Biologics/food-allergy boom, buy-and-bill margins, and private-equity roll-ups as the primary upward drivers of A&I practice revenue. ACAAI EMD (https://college.acaai.org/from-the-desk-of-the-emd-how-are-allergists-paid/); employed/RVU context from FastRVU's own planning model (https://fastrvu.com/specialties/allergy-immunology). (2026.) Corrected 2026-08-17: the "MGMA 2026" label on this line was removed for the reason given at ⁸; the host is named instead, and the ACAAI source carries the substantive claim about how allergists are paid. ↩
Burnout and happiness. Healthgrades Pro, "Happiest Physicians by Specialty" (updated 26 August 2025), relaying Medscape: physicians were asked whether doctors in their specialty could be happy and well-balanced, and allergy and immunology tops the 29 fields listed at 94%. The page publishes no burnout table. https://resources.healthgrades.com/pro/happiest-physicians-by-specialty . Healthgrades Pro, "9 Fast Facts About Burnout Among Allergists" (updated 25 September 2025), relaying Medscape's Allergist Lifestyle, Happiness & Burnout Report 2023 rather than surveying, which is how most Medscape figures reach this site: "35% of allergists reporting burnout," alongside 8% reporting depression and 14% reporting both; 76% of female allergists reported burnout and/or depression against 49% of men; and, on happiness outside of work, 55% in 2023 against 79% before the pandemic, "the 5th-least happy out of 29 specialties." https://resources.healthgrades.com/pro/5-fast-facts-about-burnout-among-allergists . One limitation of that second page belongs here: its own opening line says "around 54%," which is not the figure in its body and matches the 54% who said they would consider professional help; 35% is the number it attributes to Medscape. (2023–2025.) Corrected 2026-08-17: the dashboard, the Wellbeing section, the why-choose-it list and the FLI section all said burnout in A&I is "among the lowest of any specialty on Medscape 2024," and this footnote repeated it. Neither cited page carries that rank or any 2024 allergy figure, and the burnout page's only cross-specialty ranking of allergy is unfavorable. Medscape 2024's circulated cross-specialty tables print only that survey's highest and lowest ten specialties, and allergy is in neither; the AMA's 2025 Organizational Biopsy write-up names about 15 specialties without allergy among them; so Medscape remains the instrument for this field. The rank has been dropped rather than re-sourced, the 35% is stated with its own edition, and the unfavorable happiness measure from the same footnote now reaches the reader beside the favorable one. This matches the resolution the allergy and immunology profile reached the same day. ↩ ↩² ↩³ ↩⁴
Satisfaction / would-choose-again and the volatility caveat. SalaryDr, read in full on 2026-08-17: "Allergy & Immunology physicians rate their overall job satisfaction at 4.0 out of 5, with 90% saying they would choose this specialty again … Based on 39 verified responses" (https://www.salarydr.com/specialty/allergy-and-immunology). Corrected 2026-08-17: the "~78%" parenthetical is deleted. This footnote attributed an "older cross-specialty figure ~78%" to SalaryDr, and the string 78% appears nowhere on that page. It is one of the phantom anchors this site's own source audit names as having no current source — "seven more carried a '~78% would choose medicine again' anchor" — and it was still live here. The 90% is legitimate: SalaryDr runs its own panel and prints the n beside the figure. But this site requires the host and the n in the visible sentence, and this one gave neither, so both are now in the body. The dashboard row already carried "(SalaryDr panel, n=39)" visibly, which is the standard the wellbeing sentence has been brought onto. Medscape, "Allergists Report Sharp Decline in Work-Life Balance" (2022) — the single-year work-life-balance dip (https://www.medscape.com/viewarticle/968729). (2022–2026.) SalaryDr panel size: n=39. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩²
Dr. Burcin Fraser — AMA "What it's like in allergy & immunology: Shadowing Dr. Fraser." https://www.ama-assn.org/medical-students/preparing-residency/what-its-allergy-and-immunology-shadowing-dr-fraser ↩ ↩² ↩³
AAAAI, "A Rewarding Career in Allergy/Immunology" — draw of the field, lifelong all-ages relationships, and focus areas (food/drug allergy, immunodeficiency, eosinophilic/mast-cell disease). https://www.aaaai.org/professional-education/careers-in-a-i ↩ ↩² ↩³
A&I sex demographics — fellows in training ~68.3% women (2022), active practicing ~43.1% (up from 30.2% in 2010), faculty ~54%, program directors ~55%, division chiefs ~38%. Healio, "Women achieve equity in allergy training, faculty positions" (Jul 2023, reporting AAAAI/JACI: In Practice workforce data). https://www.healio.com/news/allergy-asthma/20230706/women-achieve-equity-in-allergy-training-faculty-positions (2023). ↩ ↩²
Dr. Alnoor Malick — AMA "What it's like in allergy & immunology: Shadowing Dr. Malick." https://www.ama-assn.org/medical-students/preparing-residency/what-it-s-allergy-immunology-shadowing-dr-malick ↩

Researched with AI assistance and reviewed by hand. How this site is made